Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Clinical Trial ID NCT02313272

PubWeight™ 4.81^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02313272

Top papers